BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18157394)

  • 1. Discordant results in Tc-99m tetrofosmin and Tc-99m sestamibi parathyroid scintigraphies.
    Duarte PS; Domingues FC; Costa MS; Brandão C; Oliveira MA; Vieira JG
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1166-8. PubMed ID: 18157394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
    Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
    J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
    Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
    Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
    Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
    Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.
    Casas AT; Burke GJ; Sathyanarayana ; Mansberger AR; Wei JP
    Am J Surg; 1993 Oct; 166(4):369-73. PubMed ID: 8214295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.
    Giordano A; Marozzi P; Meduri G; Ficola U; Calcagni ML; Vaccaro A; Rubini G; Attard M; Li Puma M; Ricci R; Corsello S
    Eur J Nucl Med; 1999 Aug; 26(8):907-11. PubMed ID: 10436206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.
    Ishibashi M; Nishida H; Strauss HW; Kojima K; Fujito H; Watanabe J; Hiromatsu Y; Hayabuchi N
    J Nucl Med; 1997 May; 38(5):706-11. PubMed ID: 9170432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
    Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
    Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
    Mansi L; Rambaldi PF; Marino G; Pecori B; Del Vecchio E
    Clin Nucl Med; 1996 Sep; 21(9):700-3. PubMed ID: 8879870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of a gamma probe for intraoperative localization of parathyroid adenomas with Tc-99m-tetrofosmin and Tc-99m-sestamibi].
    Gallowitsch HJ; Fellinger J; Kresnik E; Mikosch P; Pipam W; Unterweger OF; Lind P
    Acta Med Austriaca; 1997; 24(2):73-8. PubMed ID: 9273810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
    Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic utility of dual phase Tc-99m sestamibi parathyroid imaging.
    Klieger P; O'Mara R
    Clin Nucl Med; 1998 Apr; 23(4):208-11. PubMed ID: 9554190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of abnormal parathyroid glands with jugular sampling for parathyroid hormone, and subtraction scanning with sestamibi or tetrofosmine.
    Pattou F; Oudar C; Huglo D; Racadot A; Carnaille B; Proye C
    Aust N Z J Surg; 1998 Feb; 68(2):108-11. PubMed ID: 9494000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I.
    Caveny SA; Klingensmith WC; Martin WE; Sage-El A; McIntyre RC; Raeburn C; Wolfe P
    J Nucl Med Technol; 2012 Jun; 40(2):104-10. PubMed ID: 22566587
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans.
    Wei JP; Burke GJ; Mansberger AR
    Ann Surg; 1994 May; 219(5):568-72; discussion 572-3. PubMed ID: 8185405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism.
    Blanco I; Carril JM; Banzo I; Quirce R; Gutierrez C; Uriarte I; Montero A; Vallina NK
    Clin Nucl Med; 1998 May; 23(5):291-7. PubMed ID: 9596153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.